Prognostic Tool Can Guide Extended Endocrine Therapy in ER+ Breast Cancer

A simple prognostic tool could be used to identify patients with HR-positive breast cancer who underwent 5 years of endocrine treatment and who might be at higher risk of late distant recurrence.

Source: CancerNetwork - April 24, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer SiteTerms/www.cannabissciencetech.com/News Source Type: news